Immune recognition by cytotoxic effector T cells requires participation of the CD8 and major histocompatibility complex class I antigens. We found that the CD8 molecule is noncovalently associated with the HLA class I heavy chain on the surface of human T cells activated by Con A. Accordingly, anti-CD8 monoclonal antibodies precipitated a heterodimer containing polypeptides of32 and 43 kDa from the lysates of activated T cells. tigen and polymorphic MHC determinants (5-8). This recognition appears to be a complex process, and at least one additional cell surface component, the CD8 molecule, is implicated (4, 9-11). CD8 has been characterized as a 32-to 34-kDa integral membrane protein in its reduced form (12, 13) . Under nonreducing conditions, CD8 has been identified in a series of multimeric forms differing in inter-or intrachain disulfide bonding (13). Studies have suggested (1-4, 14-16) that CD8 can bind to MHC class I molecules and thereby increase T-cell-target or T-cell-accessory-cell avidity that allows recognition of antigen and T-cell activation. To date, however, the actual physical interaction between CD8 and MHC class I molecules on T-cell surface is not well understood. This report demonstrates a noncovalent association between CD8 and HLA heavy chain molecules on the surface of activated human T cells.
tryptic peptide mapping identified a structural similarity between this 43-kDa molecule and the HLA class I heavy chain precipitated by the anti-HLA-A, -B, and -C antibody W6/32.
Analysis of anti-CD8 precipitates under nonreducing and reducing conditions indicated a lack of interchain disulfide bonding between the CD8 and HLA heavy chain molecules. The CDS-HLA heavy chain complex was also detected in mixed lymphocyte cultures and a cloned cytotoxic T-lymphocyte line but not in purified natural killer cells. The present study indicates that CD8 is complexed with HLA heavy chain on the same cells, and the complex may have functional relevance in the T-cell recognition process.
Peripheral T lymphocytes recognize a repertoire of cellassociated antigens in the context of class I or class II molecules encoded by the major histocompatibility complex (MHC). It is generally accepted that cytotoxic T lymphocytes (CTL) recognize cell-associated viral or tumor antigens in association with MHC class I molecules (1) (2) (3) (4) and that the a/,B-chain T-cell receptor molecules on CTL recognize antigen and polymorphic MHC determinants (5) (6) (7) (8) . This recognition appears to be a complex process, and at least one additional cell surface component, the CD8 molecule, is implicated (4, (9) (10) (11) .
CD8 has been characterized as a 32-to 34-kDa integral membrane protein in its reduced form (12, 13) . Under nonreducing conditions, CD8 has been identified in a series of multimeric forms differing in inter-or intrachain disulfide bonding (13) . Studies have suggested (1-4, [14] [15] [16] ) that CD8 can bind to MHC class I molecules and thereby increase T-cell-target or T-cell-accessory-cell avidity that allows recognition of antigen and T-cell activation. To date, however, the actual physical interaction between CD8 and MHC class I molecules on T-cell surface is not well understood. This report demonstrates a noncovalent association between CD8 and HLA heavy chain molecules on the surface of activated human T cells.
MATERIALS AND METHODS Cells. Human thymocytes and peripheral blood T cells isolated by forming rosettes with sheep erythrocytes (17) were used directly for radioiodination. For Con A activation, T cells were incubated at 106 cells per ml with 10' non-T cells per ml in complete medium [RPMI 1640 medium with 5% (vol/vol) fetal bovine serum, glutamine (0.06 mg/ml), streptomycin (100 tg/ml), and penicillin (100 units/ml)] with Con A (10 pkg/ml) for 2 days. Before radioiodination, the Con A-activated T cells were washed once with 50 mM a-methyl mannoside (Sigma) and twice with isotonic phosphatebuffered saline (pH 7.2). For allogeneic activation of T cells, unseparated peripheral blood lymphocytes from two healthy donors were incubated in complete medium at 2 x 106 cells per ml for 5 days. A natural killer (NK)-enriched cell population obtained by discontinuous Percoll gradient centrifugation (18) was 80% positive for CD16, recognized by monoclonal antibody B73.1 (19) . A cloned CTL line (CD3 +, CD4 -, CD8 '), derived from peripheral blood lymphocytes sensitized with irradiated allogeneic non-T cells, was maintained in RPMI 1640 medium with 20% (vol/vol) pooled human AB serum (Flow Laboratories) and human interleukin 2 (20 units/ml) (Boehringer Mannheim). The human T-cell leukemia line HPB-ALL was from J. Minowada (Roswell Park Memorial Institute, Buffalo, NY) and was maintained in complete medium.
Antibodies. The monoclonal antibodies OKT8A (Ortho Diagnostics), anti-Leu-2a (Becton Dickinson), and C8 (20) (a gift of C. Y. Wang, United Biomedical, Lake Success, NY) recognize CD8. The anti-HLA-A, -B, and -C monoclonal antibodies W6/32 (21) and A1.4 (22) By using a reciprocal preadsorption procedure, we next determined whether depletion of CD8 from the cell lysate resulted in a decrease in quantity of 832m-free HLA heavy chain precipitated by antibody A1.4. To avoid the reaction of f82m-associated HLA heavy chain with antibody A1.4, the cell lysate was adsorbed with antibody W6/32 prior to sequential precipitation with antibodies C8 and A1.4. However, we were unable to completely remove j32m-free HLA heavy chain with antibody C8, suggesting that not all available 32m-free HLA heavy chains were complexed with CD8 (data not shown). Interestingly, precipitation with antibody A1.4 did not yield detectable CD8 (Fig. 2, lane 3) , probably due to a dissociation of CD8 and HLA molecules upon binding of antibody A1.4. This hypothesis is supported by the observation that antibody A1.4 can actually precipitate CD8 from the lysates of chemically cross-linked T cells (Y. B., unpublished data).
Chymotryptic peptide mapping further suggested that the HLA heavy chain precipitated by antibody W6/32 was identical to the 43-kDa molecule precipitated by antibody C8. Tyrosine-containing peptides of both 43-kDa molecules appeared to be identical, with some differences only in intensity of label, probably due to different accessibility of /32m-associated and CD8-complexed HLA heavy chains to iodination (Fig. 3) .
Noncovalent Bonding Between CD8 and HLA Heavy Chain.
Our adsorption experiments suggested that CD8 and HLA heavy chain were noncovalently associated, since depletion of HLA heavy chain by antibodies W6/32 and A1.4 from cell lysates did not coincidently remove CD8 (Fig. 2) . In contrast, in human thymocytes, CD8 was reported to be linked through disulfide bonds to another MHC class I-like molecule, CDi (27, 28 (Fig. 4A) . Only the anti-CD8 precipitate from the T-cell lysate, however, yielded the 43-kDa band in the absence of monomeric 32-kDa CD8, suggesting that CD8 is noncovalently associated with the HLA heavy chain (Fig. 4, lane 1 CDi (Fig. 4, lanes 6-8) , whereas the 80, 150, and 200 kDa species precipitated from the T-cell lysate contained only the 32-kDa CD8 without the 43-kDa protein (Fig. 4, lanes 3-5) .
We concluded from these experiments that the association between CD8 and HLA heavy chain in T cells is noncovalent.
Presence of the CD8-HLA Heavy Chain Complex in Activated T Cells. Since the CD8-HLA heavy chain complex was found in Con A-activated T cells but generally not in resting T cells (Fig. 1) Fig. 5 (lanes 1-6) , CTL lysates contained the CD8-HLA heavy chain complex. Existence of intrinsically labeled 32/43-kDa heterodimer (lane 2) indicated that the formation of CD8-HLA heavy chain complex was not an artifact resulting from iodination. In addition, since the CTL line represented a cloned population, the complex between CD8 and HLA heavy chain was likely to be formed on the same cells. The CD8-HLA heavy chain complex was also detected in mixed lymphocyte cultures (lane 8) but not in purified NK cells and in the HPB-ALL leukemia cell line, although these cells expressed CD8 (lanes 7 and 9) . Therefore, the CD8-HLA heavy chain complex appears to be formed only when mature T cells are activated by Con A or antigen stimulation.
DISCUSSION
Our results indicate that the CD8 molecule is associated with HLA heavy chain on the surface of activated human T cells. Resting T cells generally contain no detectable CD8-HLA heavy chain complex, the appearance of which can be induced by Con A or allogeneic stimulation. The expression of the CD8-HLA heavy chain complex in untreated T cells of donor M may be due to an in vivo activation of these T cells, as stimulation of these T cells with Con A did not alter the overall pattern of the expression of the CD8-HLA heavy chain complex. This is clearly unrelated to the HLA alleles (HLA-A26, -29 and HLA-B35, -38) of this donor, because untreated T cells of other donors with the same type of HLA alleles were negative for the CD8-HLA heavy chain complex (data not shown).
Formation of the CD8-HLA heavy chain complex is likely to occur on the same cells, rather than from two adjacent cells. This conclusion is based on the following experiments. Con A-activated T cells were first incubated with antibody C8 and then lysed, and the immune complexes were isolated Immunology: Bushkin et with goat anti-mouse IgG-agarose beads. NaDodSO4/PAGE analysis showed the presence of the CD8-HLA heavy chain complex, suggesting that the complex was formed before its reaction with antibody C8. Formation of the complex after cell lysis is unlikely, since no CD8-HLA heavy chain complex was evident in most resting T-cell preparations albeit CD8 and HLA heavy chains were present in the lysates. In another experiment, Con A-activated T cells were allowed to adhere at low density to Petri dishes precoated with poly (L-lysine) (Sigma) to avoid cell-to-cell contact during cell lysis. The CD8-HLA heavy chain complexes in the cell lysates were again found (data not shown), suggesting formation of the complex occurs on the same cells. Appearance ofthe CD8-HLA heavy chain complex only in activated T cells may result from changes during the activation process in the relative disposition ofthese molecules that leads to an increased spatial association on the cell surface. Alternatively, formation of the CD8-HLA heavy chain complex may occur intracellularly. Thus, HLA heavy chains spontaneously internalized in activated T cells (29) HLA heavy chains can complex with CD8 and be recycled to the cell surface as a CD8-HLA heavy chain complex. Enhanced expression of CD8 in activated T cells has been documented (30) , and it is possible that increased synthesis of CD8 is required for the formation of this CD8-HLA heavy chain complex. Interaction of immature thymocytes with MHC gene products present in thymic parenchyma appears to be essential for the generation of appropriate MHC-restricted T-cell clones with various functions (31, 32) . The covalent CD8-CD1 complex in thymocytes and noncovalent CD8-HLA heavy chain complex in activated mature T cells may be of functional importance. An interaction between the CD8 of effector cells and the HLA heavy chain of target cells may occur only when CD8 is present in its HLA-complexed form. Accordingly, the interaction between the effector and target cells may largely depend on the recognition between the two complexes-i.e., CD8-HLA on the effector cell and 132m-HLA on the target cell. Since the noncovalent association of j32m with MHC class I heavy chain is loose enough to allow replacement by exogenous /32m (33, 34) , the interaction between effector cell CD8 and target cell HLA molecules may be facilitated by transfer of P2m between these two complexes.
